NCT00503386View on ClinicalTrials.gov

Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
NauseaVomitingChemotherapy
Interventions
DRUG

Palonosetron

DRUG

Granisetron

Trial Locations (6)

101149

Beijing Institute on Thoracic Cancer and Tuberculosis, Beijing

210009

Jiangsu Provincial Tumor Hospital, Nanjing

310009

The Second Hospital Affiliated to Zhejiang University, Hangzhou

350014

Fujian Provincial Tumor Hospital, Fuzhou

410006

Hunan Provincial Tumor Hospital, Changsha

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
collaborator

Sun Yat-sen University

OTHER

collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Hangzhou Jiuyuan Gene Engineering Co. Ltd.,

INDUSTRY

NCT00503386 - Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting | Biotech Hunter | Biotech Hunter